Dale Curtis Hogue Jr.
Interim CEO at Alaunos Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Alaunos Therapeutics Inc., 2 years.
Chief executive roles
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-88% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alaunos Therapeutics Inc. June 6, 202477.9%
Questions about Dale Curtis Hogue Jr.
What boards is Dale Curtis Hogue Jr. on?
Dale Curtis Hogue Jr. sits on the board of Alaunos Therapeutics Inc.
What company is Dale Curtis Hogue Jr. the CEO of?
Dale Curtis Hogue Jr. has been Interim CEO of Alaunos Therapeutics Inc. since December 2023.
How long has Dale Curtis Hogue Jr. served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.